Gene · 6788
Papers1,840
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,840
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive split TEV based protein-protein interaction screening reveals TAOK2 as a key modulator of Hippo signalling to limit growth. | Cell Signal | 2024 | 37813295 | PubTator, text mining | PubMed |
| Hippo-YAP/TAZ signaling in breast cancer: Reciprocal regulation of microRNAs and implications in precision medicine. | Genes Dis | 2024 | 37692482 | PubTator, text mining | PubMed |
| The potential role of Hippo pathway regulates cellular metabolism via signaling crosstalk in disease-induced macrophage polarization. | Front Immunol | 2023 | 38274792 | PubTator, text mining | PubMed |
| Atg8 family proteins, LIR/AIM motifs and other interaction modes. | Autophagy Rep | 2023 | 38214012 | PubTator, text mining | PubMed |
| Cellular Impacts of Striatins and the STRIPAK Complex and Their Roles in the Development and Metastasis in Clinical Cancers (Review). | Cancers (Basel) | 2023 | 38201504 | PubTator, text mining | PubMed |
| Therapeutic targeting of p90 ribosomal S6 kinase. | Front Cell Dev Biol | 2023 | 38169775 | PubTator, text mining | PubMed |
| Roles and functions of IAV proteins in host immune evasion. | Front Immunol | 2023 | 38152399 | PubTator, text mining | PubMed |
| Comparative Assessment and High-Throughput Drug-Combination Profiling of TEAD-Palmitoylation Inhibitors in Hippo Pathway Deficient Mesothelioma. | Pharmaceuticals (Basel) | 2023 | 38139762 | PubTator, text mining | PubMed |
| New and Old Key Players in Liver Cancer. | Int J Mol Sci | 2023 | 38138981 | PubTator, text mining | PubMed |
| Racial Impact on Inpatient Stroke Quality of Care in Two Community Hospitals. | J Clin Med | 2023 | 38137723 | PubTator, text mining | PubMed |
| Prevalence of RAF1 Aberrations in Metastatic Cancer Patients: Real-World Data. | Biomedicines | 2023 | 38137485 | PubTator, text mining | PubMed |
| Impaired Expression of the Salvador Homolog-1 Gene Is Associated with the Development and Progression of Colorectal Cancer. | Cancers (Basel) | 2023 | 38136317 | PubTator, text mining | PubMed |
| Unleashing the Power of Yes-Associated Protein in Ferroptosis and Drug Resistance in Breast Cancer, with a Special Focus on Therapeutic Strategies. | Cancers (Basel) | 2023 | 38136274 | PubTator, text mining | PubMed |
| MicroRNA miR-212-5p Regulates the MEK/ERK Signaling Pathway by Targeting A-Raf proto-oncogene serine/threonine-protein kinase (ARAF) to Regulate Cowshed PM2.5-Induced NR8383 Apoptosis. | Toxics | 2023 | 38133382 | PubTator, text mining | PubMed |
| Hippo pathway in intestinal diseases: focusing on ferroptosis. | Front Cell Dev Biol | 2023 | 38130953 | PubTator, text mining | PubMed |
| Pharmacological inhibition of CLK2 activates YAP by promoting alternative splicing of AMOTL2. | Elife | 2023 | 38126343 | PubTator, text mining | PubMed |
| Targeting CRAF kinase in anti-cancer therapy: progress and opportunities. | Mol Cancer | 2023 | 38111008 | PubTator, text mining | PubMed |
| Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies. | Signal Transduct Target Ther | 2023 | 38105263 | PubTator, text mining | PubMed |
| Regulatory mechanism of macrophage polarization based on Hippo pathway. | Front Immunol | 2023 | 38090595 | PubTator, text mining | PubMed |
| New Insights into YAP/TAZ-TEAD-Mediated Gene Regulation and Biological Processes in Cancer. | Cancers (Basel) | 2023 | 38067201 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6788/papers?page=5